Newcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, today announced the launch of its imaging suite and advanced lung Fibroblast-to-Myofibroblast Transition (FMT) assay.
Twist Bioscience lays off 212 staffers, mostly in San Francisco
Twist Bioscience is laying off 212 employees, effective July 3, according to California WARN notices — with 197 of those staffers in San Francisco. The